410 related articles for article (PubMed ID: 33011173)
1. Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry.
Kelly CR; Yen EF; Grinspan AM; Kahn SA; Atreja A; Lewis JD; Moore TA; Rubin DT; Kim AM; Serra S; Nersesova Y; Fredell L; Hunsicker D; McDonald D; Knight R; Allegretti JR; Pekow J; Absah I; Hsu R; Vincent J; Khanna S; Tangen L; Crawford CV; Mattar MC; Chen LA; Fischer M; Arsenescu RI; Feuerstadt P; Goldstein J; Kerman D; Ehrlich AC; Wu GD; Laine L
Gastroenterology; 2021 Jan; 160(1):183-192.e3. PubMed ID: 33011173
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry.
Yau YK; Lau LHS; Lui RNS; Wong SH; Guo CL; Mak JWY; Ching JYL; Ip M; Kamm MA; Rubin DT; Chan PKS; Chan FKL; Ng SC
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):611-620.e12. PubMed ID: 37734581
[TBL] [Abstract][Full Text] [Related]
3. Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort.
Suchman K; Luo Y; Grinspan A
Dig Dis Sci; 2022 Oct; 67(10):4866-4873. PubMed ID: 35000023
[TBL] [Abstract][Full Text] [Related]
4. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Vaughn BP; Fischer M; Kelly CR; Allegretti JR; Graiziger C; Thomas J; McClure E; Kabage AJ; Khoruts A
Clin Gastroenterol Hepatol; 2023 May; 21(5):1330-1337.e2. PubMed ID: 36126907
[TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer.
Borody TJ; Eslick GD; Clancy RL
Curr Opin Pharmacol; 2019 Dec; 49():43-51. PubMed ID: 31173991
[TBL] [Abstract][Full Text] [Related]
7. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
Luo Y; Tixier EN; Grinspan AM
Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.
Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M
Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388
[TBL] [Abstract][Full Text] [Related]
9. Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Saha S; Mara K; Pardi DS; Khanna S
Gastroenterology; 2021 May; 160(6):1961-1969.e3. PubMed ID: 33444573
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center.
Ianiro G; Bibbò S; Porcari S; Settanni CR; Giambò F; Curta AR; Quaranta G; Scaldaferri F; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G
Gut Microbes; 2021; 13(1):1994834. PubMed ID: 34709989
[TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series.
Urbonas T; Ianiro G; Gedgaudas R; Sabanas P; Urba M; Kiudelis V; Kiudelis G; Petkevicius V; Vitkauskiene A; Cammarota G; Gasbarrini A; Kupcinskas J
J Gastrointestin Liver Dis; 2021 Dec; 30(4):470-476. PubMed ID: 34752587
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease : A Systematic Review and Meta-analysis.
Tariq R; Syed T; Yadav D; Prokop LJ; Singh S; Loftus EV; Pardi DS; Khanna S
J Clin Gastroenterol; 2023 Mar; 57(3):285-293. PubMed ID: 34864789
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT).
Allegretti JR; Kassam Z; Fischer M; Kelly C; Chan WW
J Clin Gastroenterol; 2019 Oct; 53(9):e405-e408. PubMed ID: 30882536
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S
Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444
[TBL] [Abstract][Full Text] [Related]
15. Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.
Mahmoudi H; Hossainpour H
Saudi J Gastroenterol; 2023; 29(1):3-11. PubMed ID: 36412458
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children.
Nicholson MR; Mitchell PD; Alexander E; Ballal S; Bartlett M; Becker P; Davidovics Z; Docktor M; Dole M; Felix G; Gisser J; Hourigan SK; Jensen MK; Kaplan JL; Kelsen J; Kennedy M; Khanna S; Knackstedt E; Leier M; Lewis J; Lodarek A; Michail S; Oliva-Hemker M; Patton T; Queliza K; Russell GH; Singh N; Solomon A; Suskind DL; Werlin S; Kellermayer R; Kahn SA
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):612-619.e1. PubMed ID: 31009795
[TBL] [Abstract][Full Text] [Related]
17. Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation.
Dawwas GK; Brensinger CM; Vajravelu RK; Wu Q; Kelly CR; Laine L; Wu GD; Lewis JD
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):806-816.e6. PubMed ID: 33307184
[TBL] [Abstract][Full Text] [Related]
18. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
[TBL] [Abstract][Full Text] [Related]
19. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
[TBL] [Abstract][Full Text] [Related]
20. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
Saha S; Mara K; Pardi DS; Khanna S
Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
